Results 61 to 70 of about 74,737 (254)

Guillain-Barré syndrome following COVID-19: new infection, old complication?

open access: yesJournal of Neurology, 2020
The coronavirus disease-2019 (COVID-19) pandemic originated in Wuhan (China) on December 2019. So far, more than 1,500,000 cases have been confirmed worldwide (> 150,000 cases in Italy) [1].
M. Padroni   +8 more
semanticscholar   +1 more source

Guillain-Barré syndrome in temporal association with influenza A vaccine [PDF]

open access: yes, 2011
OBJECTIVE: To report a case of Guillain-Barré syndrome following influenza A (H1N1) 2009 vaccine. CASE DESCRIPTION: A four-year-old boy presented right thigh pain and ascending muscular weakness 15 days after the second dose of influenza A (H1N1) 2009 ...
Ferrarini, Maria Aparecida G   +5 more
core   +3 more sources

Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial.

open access: yesLancet Neurology, 2021
BACKGROUND Treatment with one standard dose (2 g/kg) of intravenous immunoglobulin is insufficient in a proportion of patients with severe Guillain-Barré syndrome.
C. Walgaard   +119 more
semanticscholar   +1 more source

Guillain-Barré syndrome after AstraZeneca COVID-19-vaccination: A causal or casual association?

open access: yesClinical neurology and neurosurgery (Dutch-Flemish ed. Print), 2021
We report a case of Guillain-Barré syndrome (GBS) following the first dose of Oxford/AstraZeneca COVID-19 vaccine with papilledema as atypical onset. As the COVID-19 vaccination campaign progresses worldwide, GBSs vaccine-related have been increasingly ...
Alessandro Introna   +6 more
semanticscholar   +1 more source

Differential binding patterns of anti-sulfatide antibodies to glial membranes [PDF]

open access: yes, 2018
Sulfatide is a major glycosphingolipid in myelin and a target for autoantibodies in autoimmune neuropathies. However neuropathy disease models have not been widely established, in part because currently available monoclonal antibodies to sulfatide may ...
Barrie, Jennifer A.   +8 more
core   +1 more source

Machine Learning‐Assisted Infectious Disease Detection in Low‐Income Areas: Toward Rapid Triage of Dengue and Zika Virus Using Open‐Source Hardware

open access: yesAdvanced Intelligent Discovery, EarlyView.
This study introduces an affordable machine learning platform for simultaneous dengue and zika detection using fluorine‐doped tin oxide thin films modified with gold nanoparticles and DNA aptamers. Designed for low‐cost, hardware‐limited devices (< $25), the model achieves 95.3% accuracy and uses only 9.4 kB of RAM, demonstrating viability for resource‐
Marina Ribeiro Batistuti Sawazaki   +3 more
wiley   +1 more source

Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital

open access: yesNeurological Sciences, 2020
Guillain-Barré syndrome (GBS) is an acute polyradiculoneuropathy associated with dysimmune processes, often related to a previous infectious exposure.
D. Ottaviani   +7 more
semanticscholar   +1 more source

Intensive Care and Treatment of Severe Guillain–Barré Syndrome

open access: yesFrontiers in Pharmacology, 2021
Guillain–Barré syndrome (GBS) is an acute polyneuropathy mostly characterized by acute flaccid paralysis with or without sensory/autonomous nerve dysfunction. Current immuno therapies including intravenous immunoglobulin (IVIg), plasma exchange (PE), and
Pei Shang   +3 more
semanticscholar   +1 more source

Guillain-Barre syndrome (GBS) [PDF]

open access: yes, 2013
A 57-year-old Caucasian gentleman presented with bilateral progressive distal upper limb paraesthesiae, which he described as a feeling of “heaviness” followed by distal lower limb and mild tongue parasthaesia.
Grima, Maria Angela
core  

The intersection of health inequalities and COVID‐19: Evidence from National Health Insurance Big Data in South Korea

open access: yesAmerican Journal of Community Psychology, EarlyView.
Abstract Health inequalities persist along lines of income and wealth, shaped by unequal access to healthcare, differences in health behaviors, and pre‐existing chronic conditions. The COVID‐19 pandemic further put families in Korea under health strain and worsened their health outcomes.
Jaehyun Nam   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy